PTHS - Chromocell Therapeutics Corp
23
0.050 0.217%
Share volume: 18,667
Last Updated: 04-21-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.21%
PREVIOUS CLOSE
CHG
CHG%
$22.95
0.05
0.00%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 03-27-2025 | 05-13-2025 | 11-13-2025 | 03-19-2026 | |
| Assets | |||||
| Total Assets | 1.369 M | 911.179 K | 126.433 M | 130.397 M | |
| Current Assets | 1.369 M | 911.179 K | 49.761 M | 53.410 M | |
| Inventories | 0.000 | 0.000 | 24.096 M | 23.574 M | |
| Other Current Assets | 790.400 K | 763.525 K | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 513.443 K | 131.317 K | 14.203 M | 17.973 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 10.174 M | 9.586 M | |
| Other Assets | 0.000 | 0.000 | 66.498 M | 67.401 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||
| Total Liabilities and shareholders’ equity | 1.369 M | 911.179 K | 126.433 M | 130.397 M | |
| Total liabilities | 4.083 M | 5.107 M | 68.180 M | 91.516 M | |
| Total current liabilities | 4.083 M | 5.107 M | 24.768 M | 25.993 M | |
| Accounts Payable | 1.897 M | 2.604 M | 5.666 M | 2.986 M | |
| Other liabilities | 0.000 | 0.000 | 26.175 M | 32.802 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 31.441 M | |
| Other liabilities | 0.000 | 0.000 | 26.175 M | 32.802 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -2.714 M | -4.196 M | 58.253 M | 38.881 M | |
| Common stock | 18.761 M | 19.247 M | 101.383 M | 103.675 M | |
| Retained earnings | -21.475 M | -23.443 M | -43.130 M | -64.794 M |